Table 1.

MiR-92a expression in colorectal cancer (CRC) versus control.

Sample Source	Author	Year	Region	Case/Control	Fold Change	p
Tissue				744/635	2.64 ± 1.30	<0.0001
	Ng et al. [18]	2009	China	5/5	2.58	<0.05
	Earle et al. [30]	2010	USA	55/55	1.75	<0.0001
	Koga et al. [20]	2010	Japan	31/31	1.81	0.01
	Ma et al. [31]	2011	China	12/12	1.17	<0.05
	Wu et al. [21]	2011	China	40/40	2.18	<0.0001
	Wang et al. [23]	2012	China	57/15	2	<0.0001
	Nishida et al. [32]	2012	Japan	13/4	2.8842	<0.0001
	Ragusa et al. [33]	2012	Italy	22/5	up 1	<0.05
	Neerincx et al. [34]	2015	Holland	40/23	1.866	<0.0001
	Al-Sheikh et al. [35]	2016	Saudi Arabia	20/20	2.6	<0.01
	Jepsen et al. [36]	2016	Denmark	9/3	1.68	0.002
	Uratani et al. [37]	2016	USA	19/20	up	<0.001
	Slattery et al. [38]	2018	USA	217/217	2.95	0.0009
	Chang et al. [8]	2016	China	62/62	1.9	<0.001
	Brînzan et al. [28]	2020	Romania	82/82	2.32	<0.001
	Fellizar et al. [40]	2022	Philippines	41/41	7.41	<0.001
Stool				766/721	5.07 ± 3.07	<0.0001
	Koga et al. [20]	2010	Japan	197/119	8.3	<0.0001
	Wu et al. [21]	2011	China	88/101	up	<0.0001
	Chang et al. [8]	2016	China	62/62	3.48	<0.0001
	Xue et al. [24]	2016	China	50/50	1.08	<0.01
	Choi et al. [26]	2019	Korea	29/29	2.12	0.001
	Xu et al. [42]	2022	China	340/360	1.33	<0.0001
Blood				835/598	28.42 ± 49.09	<0.0001
	Ng et al. [18]	2009	China	5/5	4.45	<0.05
	Huang et al. [19]	2010	China	100/59	up	<0.0001
	Giráldez et al. [16]	2013	Spain	21/20	1.83	0.0437
	Liu et al. [22]	2013	China	200/80	up	<0.05
	Chang et al. [8]	2016	China	62/62	2.85	<0.0001
	Elshafei et al. [25]	2017	Egypt	64/27	3.38	<0.0001
	Luo et al. [27]	2019	China	57/125	up	0.007
	Shi et al. [7]	2020	China	148/68	up	<0.001
	Hassan et al. [17]	2020	Egypt	33/30	158.83	<0.05
	Elaguizy et al. [29]	2020	Egypt	50/50	1.879	0.003
	Zaki et al. [39]	2022	Egypt	54/15	62.2	<0.001
	Fellizar et al. [40]	2022	Philippines	36/36	2.5	<0.001
	Kim et al. [41]	2022	Korea	5/21	up	<0.001

¹ Note: up means it could not point to the exact fold change number but still showed the higher expression in CRC.